Evaxion Biotech A/S ( EVAX) - Key Metrics
EVAX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0 | -$0.93 | -$1.04 | -$1.04 |
| 2025Q3 | $6.78 | $4.18 | ? | ? |
| 2025Q2 | $0.03 | -$4.37 | ? | ? |
| 2025Q1 | ? | -$1.43 | ? | ? |
| 2024Q4 | $0.11 | -$3.38 | ? | ? |
EVAX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -1.29 |
| 2025Q3 | ? | 0.22 |
| 2025Q2 | ? | -0.14 |
| 2025Q1 | ? | -0.32 |
| 2024Q4 | ? | -0.31 |
EVAX
Price: $3.55
52 week price:
Earnings Per Share: -1.00 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Denmark
Volume: 302177
Market Capitalization: 22.4 million